KYMR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.98%

Insider Buying (Last 12 Months): $172,499,918.00

Insider Selling (Last 12 Months): $464,506,228.91

Kymera Therapeutics Insider Trading History Chart

Kymera Therapeutics Share Price & Price History

^$117.75

▼ -0.73 (-0.62%)

As of 09/18/2026 04:00 PM ET

Days: 30 | 90 | 365

Kymera Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/4/2026	Brian Adams	Insider	Sell	6,371	$116.83	$744,323.93	50,254
7/7/2026	Nello Mainolfi	CEO	Sell	50,000	$119.00	$5,950,000.00	666,568
7/1/2026	Nello Mainolfi	CEO	Sell	80,000	$115.29	$9,223,200.00	666,568
7/1/2026	Noah Goodman	Insider	Sell	3,389	$114.29	$387,328.81	47,179
6/30/2026	Bruce N. Jacobs	CFO	Sell	77,109	$114.96	$8,864,450.64	244,883
6/29/2026	Bruce Booth	Director	Sell	31,283	$109.48	$3,424,862.84	461,794
6/29/2026	Bruce Booth	Director	Sell	45,367	$107.06	$4,856,991.02	466,077
6/26/2026	Bruce Booth	Director	Sell	467,878	$110.29	$51,602,264.62	472,267
6/26/2026	Bvf Partners L P/Il	Director	Sell	1,578,800	$106.50	$168,142,200.00	240,123
6/26/2026	Bvf Partners L P/Il	Director	Sell	51,858	$106.50	$5,522,877.00	78,787
6/25/2026	Bruce Booth	Director	Sell	262,637	$115.39	$30,305,683.43	564,668
6/25/2026	Bruce Booth	Director	Sell	285,684	$121.86	$34,813,452.24	529,718
6/25/2026	Noah Goodman	Insider	Sell	5,000	$114.00	$570,000.00	50,195
6/24/2026	Bruce Booth	Director	Sell	134,720	$100.51	$13,540,707.20	597,047
6/23/2026	Bruce Booth	Director	Sell	1,408	$99.98	$140,771.84	613,589
6/22/2026	Bruce Booth	Director	Sell	246,330	$98.52	$24,268,431.60	617,663
6/22/2026	Bruce Booth	Director	Sell	31,798	$103.75	$3,299,042.50	613,762
6/22/2026	Noah Goodman	Insider	Sell	2,500	$99.00	$247,500.00	50,195
6/18/2026	Bruce Booth	Director	Sell	115,056	$91.01	$10,471,246.56	647,914
6/17/2026	Bruce Booth	Director	Sell	11,741	$89.98	$1,056,455.18	11,741
6/17/2026	Bruce Booth	Director	Sell	105,071	$90.38	$9,496,316.98	662,042
5/27/2026	Jeremy G. Chadwick	COO	Sell	4,279	$81.58	$349,080.82	44,018
5/26/2026	Jeremy G. Chadwick	COO	Sell	12,905	$79.36	$1,024,140.80	48,297
5/11/2026	Elena Ridloff	Director	Sell	3,000	$87.00	$261,000.00	3,000
4/29/2026	Nello Mainolfi	CEO	Sell	30,000	$81.18	$2,435,400.00	666,195
4/22/2026	Bruce Booth	Director	Sell	5,900	$89.96	$530,764.00	5,641
4/22/2026	Bruce Booth	Director	Sell	100	$90.08	$9,008.00	674,944
4/22/2026	Jeremy G. Chadwick	COO	Sell	300	$90.00	$27,000.00	61,202
4/15/2026	Bruce Booth	Director	Sell	2,200	$89.95	$197,890.00	4,159
4/15/2026	Bruce Booth	Director	Sell	3,135	$90.10	$282,463.50	674,956
4/15/2026	Jeremy G. Chadwick	COO	Sell	1,300	$90.00	$117,000.00	61,202
4/14/2026	Bruce Booth	Director	Sell	4,159	$89.97	$374,185.23	4,159
4/14/2026	Jeremy G. Chadwick	COO	Sell	5,251	$90.00	$472,590.00	61,202
4/14/2026	Noah Goodman	Insider	Sell	1,347	$90.00	$121,230.00	50,195
4/10/2026	Noah Goodman	Insider	Sell	2,000	$87.35	$174,700.00	51,542
4/9/2026	Noah Goodman	Insider	Sell	8,264	$87.50	$723,100.00	53,542
4/1/2026	Elena Ridloff	Director	Sell	4,600	$85.42	$392,932.00
4/1/2026	Jeremy G. Chadwick	COO	Sell	14,640	$85.46	$1,251,134.40	61,202
3/31/2026	Elena Ridloff	Director	Sell	7,400	$85.37	$631,738.00
3/31/2026	Jeremy G. Chadwick	COO	Sell	7,600	$85.38	$648,888.00	61,202
3/25/2026	Jeremy G. Chadwick	COO	Sell	24,727	$80.26	$1,984,589.02	61,202
3/23/2026	Jeremy G. Chadwick	COO	Sell	91,250	$77.41	$7,063,662.50	61,202
3/11/2026	Jeremy G. Chadwick	COO	Sell	25,758	$83.30	$2,145,641.40	68,052
3/4/2026	Bruce N. Jacobs	CFO	Sell	4,895	$85.30	$417,543.50	232,588
3/4/2026	Jared Gollob	Insider	Sell	4,895	$85.30	$417,543.50	117,134
3/4/2026	Jeremy G. Chadwick	COO	Sell	3,919	$85.30	$334,290.70	73,810
3/2/2026	Bruce Booth	Director	Sell	81,866	$90.13	$7,378,582.58	675,341
3/2/2026	Bruce N. Jacobs	CFO	Sell	7,576	$88.93	$673,733.68	237,483
3/2/2026	Jared Gollob	Insider	Sell	5,613	$88.93	$499,164.09	122,029
3/2/2026	Jeremy G. Chadwick	COO	Sell	2,039	$88.93	$181,328.27	77,729
2/25/2026	Nello Mainolfi	CEO	Sell	30,000	$90.26	$2,707,800.00	666,195
12/31/2025	Nello Mainolfi	CEO	Sell	30,000	$78.06	$2,341,800.00	663,077
12/12/2025	Bruce Booth	Director	Sell	678	$91.04	$61,725.12	685,393
12/11/2025	Bros. Advisors Lp Baker	Director	Buy	2,005,813	$86.00	$172,499,918.00	7,955,916
12/11/2025	Bruce Booth	Director	Sell	6,101	$91.23	$556,594.23	685,501
12/10/2025	Bruce Booth	Director	Sell	229,809	$91.73	$21,080,379.57	686,477
12/8/2025	Jared Gollob	Insider	Sell	49,307	$88.67	$4,372,051.69	109,992
12/8/2025	Jeffrey W Albers	Director	Sell	5,000	$89.76	$448,800.00
12/8/2025	Nello Mainolfi	CEO	Sell	100,000	$89.17	$8,917,000.00	660,482
10/29/2025	Nello Mainolfi	CEO	Sell	30,000	$60.99	$1,829,700.00	660,482
10/15/2025	Jared Gollob	Insider	Sell	59,576	$61.42	$3,659,157.92	109,992
10/13/2025	Jared Gollob	Insider	Sell	3,114	$60.00	$186,840.00	118,359
10/13/2025	Jeffrey W Albers	Director	Sell	5,000	$59.19	$295,950.00
9/17/2025	Bruce N. Jacobs	CFO	Sell	79,220	$50.00	$3,961,000.00	227,409
9/16/2025	Nello Mainolfi	CEO	Sell	30,000	$49.00	$1,470,000.00	660,482
6/30/2025	Bros. Advisors Lp Baker	Director	Buy	655,500	$44.00	$28,842,000.00	6,117,295
6/30/2025	Bvf Partners L P/Il	Director	Buy	317,167	$44.00	$13,955,348.00	2,798,795
6/3/2025	Elena Ridloff	Director	Sell	12,000	$46.10	$553,200.00
6/3/2025	Jeffrey W. Albers	Director	Sell	6,349	$49.00	$311,101.00
6/3/2025	Nello Mainolfi	CEO	Sell	30,000	$49.00	$1,470,000.00	660,482
3/3/2025	Bruce N. Jacobs	CFO	Sell	7,035	$30.45	$214,215.75	201,886
3/3/2025	Ellen Chiniara	Insider	Sell	2,241	$30.45	$68,238.45	80,085
3/3/2025	Jeremy G. Chadwick	COO	Sell	1,383	$30.45	$42,112.35	67,800
1/6/2025	Ellen Chiniara	Insider	Sell	3,129	$41.75	$130,635.75	54,826
9/17/2024	Pamela Esposito	Director	Sell	13,500	$48.28	$651,780.00
8/26/2024	Jeffrey W. Albers	Director	Sell	5,000	$49.10	$245,500.00
7/16/2024	Jared Gollob	Insider	Sell	23,145	$45.81	$1,060,272.45	95,470
7/9/2024	Bruce Booth	Director	Sell	453,960	$38.21	$17,345,811.60	723,246
6/12/2024	Bruce Booth	Director	Sell	16,740	$35.45	$593,433.00	803,792
6/7/2024	Joanna Horobin	Director	Sell	8,500	$32.99	$280,415.00
3/15/2024	Bruce Booth	Director	Sell	71,764	$40.46	$2,903,571.44	806,697
3/13/2024	Bruce Booth	Director	Sell	139,255	$42.23	$5,880,738.65	828,830
3/13/2024	Venture Fund X L.P. Atlas	Major Shareholder	Sell	115,090	$42.23	$4,860,250.70	4,676,075
3/11/2024	Bruce Booth	Director	Sell	51,184	$42.85	$2,193,234.40	881,266
3/11/2024	Venture Fund X L.P. Atlas	Major Shareholder	Sell	42,302	$42.85	$1,812,640.70	4,925,812
3/4/2024	Bruce N. Jacobs	CFO	Sell	3,934	$41.86	$164,677.24	142,351
2/21/2024	Jeffrey W. Albers	Director	Sell	4,385	$39.05	$171,234.25
2/9/2024	Jared Gollob	Insider	Sell	46,137	$35.50	$1,637,863.50	74,709
1/23/2024	Jeffrey W. Albers	Director	Sell	10,000	$30.05	$300,500.00
1/4/2024	Ellen Chiniara	Insider	Sell	3,295	$22.58	$74,401.10	34,205
11/2/2023	Bvf Partners L P/Il	Director	Buy	216,406	$11.64	$2,518,965.84	2,552,306

SEC Filings (Institutional Ownership Changes) for Kymera Therapeutics (NASDAQ:KYMR)

Institutional Buying and Selling by Quarter

Kymera Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/9/2026	Squarepoint Ops LLC	97,189	$11.15M	0.0%	+657.0%	0.117%
9/8/2026	Arizona State Retirement System	12,390	$1.42M	0.0%	-5.5%	0.015%
9/8/2026	Nykredit A S	1,807	$0.21M	0.0%	N/A	0.002%
9/2/2026	Allianz Asset Management GmbH	4,500	$0.52M	0.0%	N/A	0.005%
8/25/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	3,000	$0.34M	0.0%	N/A	0.004%
8/23/2026	DMC Group LLC	2,000	$0.23M	0.2%	N/A	0.002%
8/21/2026	Atlas Venture Life Science Advisors LLC	2,847,541	$326.53M	37.1%	-37.8%	3.425%
8/21/2026	Braidwell LP	378,163	$43.36M	1.6%	+12.0%	0.455%
8/21/2026	Nykredit A S	1,807	$0.21M	0.0%	N/A	0.002%
8/20/2026	Proficio Capital Partners LLC	11,045	$1.27M	0.0%	+1.8%	0.013%
8/20/2026	Yiheng Capital Management L.P.	63,440	$7.28M	2.5%	-13.6%	0.076%
8/20/2026	Two Sigma Securities LLC	2,716	$0.31M	0.0%	N/A	0.003%
8/20/2026	Alyeska Investment Group L.P.	276,455	$31.70M	0.1%	-19.3%	0.332%
8/19/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	736,866	$84.50M	0.0%	-15.9%	0.886%
8/19/2026	Wellington Management Group LLP	3,675,028	$421.42M	0.1%	-5.5%	4.420%
8/18/2026	Beacon Pointe Advisors LLC	2,301	$0.26M	0.0%	N/A	0.003%
8/18/2026	Empowered Funds LLC	2,338	$0.27M	0.0%	N/A	0.003%
8/17/2026	Proficio Capital Partners LLC	11,045	$1.27M	0.0%	N/A	0.013%
8/17/2026	Bamco Inc. NY	20,000	$2.29M	0.0%	N/A	0.024%
8/17/2026	Bank of America Corp DE	378,286	$43.38M	0.0%	N/A	0.455%
8/17/2026	Boone Capital Management LLC	113,173	$12.98M	3.0%	N/A	0.136%
8/15/2026	Freestone Grove Partners LP	21,176	$2.43M	0.0%	N/A	0.025%
8/15/2026	Odyssean LLC	34,485	$3.95M	0.6%	+132.7%	0.041%
8/15/2026	Man Group plc	19,085	$2.19M	0.0%	N/A	0.023%
8/15/2026	Jupiter Topco LLC	21,058	$2.42M	0.0%	N/A	0.025%
8/14/2026	Nicholas Investment Partners LP	54,569	$6.26M	0.4%	N/A	0.066%
8/14/2026	Legal & General Group Plc	36,237	$4.16M	0.0%	N/A	0.044%
8/14/2026	The Manufacturers Life Insurance Company	119,503	$13.70M	0.0%	N/A	0.144%
8/14/2026	Brandywine Managers LLC	7,570	$0.87M	0.4%	N/A	0.009%
8/14/2026	Nan Fung Group Holdings Ltd	30,875	$3.54M	0.0%	N/A	0.037%
8/14/2026	Algert Global LLC	3,430	$0.39M	0.0%	-29.0%	0.004%
8/13/2026	Connor Clark & Lunn Investment Management Ltd.	149,908	$17.19M	0.0%	N/A	0.180%
8/11/2026	B. Metzler seel. Sohn & Co. AG	12,083	$1.39M	0.0%	N/A	0.015%
8/11/2026	E Fund Management Co. Ltd.	5,209	$0.60M	0.0%	N/A	0.006%
8/10/2026	Eagle Health Investments LP	166,148	$19.05M	3.2%	N/A	0.200%
8/7/2026	Merck & Co. Inc.	772,165	$88.54M	0.0%	N/A	0.939%
8/7/2026	BlackRock Inc.	5,538,210	$635.07M	0.0%	N/A	6.733%
8/7/2026	Deutsche Bank AG	106,049	$12.16M	0.0%	N/A	0.129%
8/7/2026	TimesSquare Capital Management LLC	157,327	$18.04M	0.3%	N/A	0.191%
8/6/2026	Bank of New York Mellon Corp	215,588	$24.72M	0.0%	N/A	0.262%
8/6/2026	State of Wyoming	11,780	$1.35M	0.1%	N/A	0.014%
8/6/2026	GSA Capital Partners LLP	7,343	$0.84M	0.1%	N/A	0.009%
7/10/2026	Handelsbanken Fonder AB	20,700	$2.37M	0.0%	+15.0%	0.025%
7/7/2026	GAMMA Investing LLC	454	$52K	0.0%	+27.5%	0.001%
6/16/2026	Empowered Funds LLC	2,438	$0.20M	0.0%	N/A	0.003%
5/26/2026	Glenmede Trust Co. NA	6,779	$0.57M	0.0%	+3.6%	0.008%
5/19/2026	Bank of America Corp DE	289,416	$24.11M	0.0%	-14.6%	0.352%
5/18/2026	Amundi	2,988	$0.25M	0.0%	N/A	0.004%
5/18/2026	California State Teachers Retirement System	56,282	$4.69M	0.0%	+23.0%	0.068%
5/18/2026	Royal Bank of Canada	730	$60K	0.0%	-67.7%	0.001%
5/18/2026	Eagle Health Investments LP	145,816	$12.15M	2.1%	+7.0%	0.177%
5/18/2026	Empowered Funds LLC	2,438	$0.20M	0.0%	N/A	0.003%
5/16/2026	The Manufacturers Life Insurance Company	120,151	$10.01M	0.0%	-11.6%	0.146%
5/15/2026	Octagon Capital Advisors LP	425,000	$35.40M	3.9%	-20.6%	0.517%
5/14/2026	Atlas Venture Life Science Advisors LLC	4,578,008	$381.30M	48.3%	-1.8%	5.565%
5/14/2026	Siren L.L.C.	3,186,830	$265.43M	7.4%	-3.0%	3.874%
5/14/2026	Inceptionr LLC	3,618	$0.30M	0.1%	N/A	0.004%
5/14/2026	Sei Investments Co.	11,225	$0.94M	0.0%	-15.3%	0.014%
5/14/2026	Monashee Investment Management LLC	35,100	$2.92M	1.6%	-64.9%	0.043%
5/13/2026	Cetera Investment Advisers	3,602	$0.30M	0.0%	+7.5%	0.004%
5/13/2026	First Trust Advisors LP	93,617	$7.80M	0.0%	+59.0%	0.114%
5/8/2026	PNC Financial Services Group Inc.	1,285	$0.11M	0.0%	+56.3%	0.002%
5/7/2026	WCM Investment Management LLC	152,381	$12.11M	0.0%	+44.9%	0.185%
5/7/2026	Dimensional Fund Advisors LP	592,879	$49.36M	0.0%	-5.0%	0.721%
5/7/2026	AlphaCentric Advisors LLC	5,342	$0.45M	0.4%	+6.1%	0.006%
5/7/2026	Swiss National Bank	94,500	$7.87M	0.0%	+0.3%	0.115%
5/6/2026	Jennison Associates LLC	508,999	$42.40M	0.0%	+2.5%	0.619%
5/5/2026	Marks Group Wealth Management Inc	4,003	$0.33M	0.0%	N/A	0.005%
5/5/2026	Bank of New York Mellon Corp	193,200	$16.09M	0.0%	+0.2%	0.235%
5/4/2026	Principal Financial Group Inc.	4,147	$0.35M	0.0%	+24.4%	0.005%
5/1/2026	Fifth Third Bancorp	51,238	$4.27M	0.0%	N/A	0.063%
4/28/2026	Abel Hall LLC	4,833	$0.40M	0.1%	-17.2%	0.006%
4/22/2026	Pictet Asset Management Holding SA	468,728	$38.76M	0.0%	-3.0%	0.574%
4/20/2026	Keudell Morrison Wealth Management	6,990	$0.58M	0.1%	+5.9%	0.009%
4/16/2026	SG Americas Securities LLC	3,163	$0.26M	0.0%	-86.1%	0.004%
3/20/2026	Hsbc Holdings PLC	7,619	$0.60M	0.0%	-26.1%	0.009%
3/17/2026	Rockefeller Capital Management L.P.	25,533	$1.99M	0.0%	+21,538.1%	0.031%
3/3/2026	Caitong International Asset Management Co. Ltd	2,542	$0.20M	0.0%	N/A	0.003%
2/23/2026	Virtu Financial LLC	27,283	$2.12M	0.1%	N/A	0.038%
2/19/2026	T. Rowe Price Investment Management Inc.	629,745	$49M	0.0%	+3.0%	0.875%
2/19/2026	Invesco Ltd.	116,747	$9.08M	0.0%	+46.3%	0.162%
2/18/2026	Vident Advisory LLC	7,581	$0.59M	0.0%	+6.5%	0.011%
2/18/2026	Mackenzie Financial Corp	3,464	$0.27M	0.0%	N/A	0.005%
2/18/2026	XTX Topco Ltd	24,143	$1.88M	0.0%	N/A	0.034%
2/18/2026	Yiheng Capital Management L.P.	73,440	$5.71M	1.2%	-40.1%	0.102%
2/18/2026	Virtus Investment Advisers LLC	2,966	$0.23M	0.1%	+23.3%	0.004%
2/18/2026	Wellington Management Group LLP	4,412,933	$343.37M	0.1%	-15.1%	6.133%
2/18/2026	RTW Investments LP	240,000	$18.67M	0.2%	N/A	0.334%
2/18/2026	Odyssean LLC	9,347	$0.73M	0.5%	N/A	0.013%
2/18/2026	Perceptive Advisors LLC	69,935	$5.44M	0.1%	-58.8%	0.097%
2/18/2026	Millennium Management LLC	11,243	$0.88M	0.0%	-88.2%	0.016%
2/18/2026	Man Group plc	20,026	$1.56M	0.0%	N/A	0.028%
2/18/2026	Janus Henderson Group PLC	21,058	$1.64M	0.0%	+15.0%	0.029%
2/18/2026	Clough Capital Partners L P	10,925	$0.85M	0.1%	N/A	0.015%
2/18/2026	Baker BROS. Advisors LP	8,657,242	$673.62M	3.9%	+30.2%	12.032%
2/18/2026	Bamco Inc. NY	20,000	$1.56M	0.0%	+185.7%	0.028%
2/18/2026	Armistice Capital LLC	81,165	$6.32M	0.1%	N/A	0.113%
2/17/2026	Guggenheim Capital LLC	10,307	$0.80M	0.0%	N/A	0.014%
2/17/2026	Logos Global Management LP	130,000	$10.12M	0.6%	-48.0%	0.181%
2/17/2026	AQR Capital Management LLC	9,339	$0.73M	0.0%	+8.3%	0.013%

Data available starting January 2016

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company develops STAT6, a Type 2 inflammation in allergic diseases; and TYK2, a treatment for inflammatory bowel disease, psoriasis, psoriatic arthritis, and lupus. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $117.75

$116.36

$119.06

50 Day Range

MA: $114.36

$100.31

$127.31

52 Week Range

Now: $117.75

$47.90

$130.05

Volume

1,900,263 shs

Average Volume

599,332 shs

Market Capitalization

$9.79 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.96

Who are the company insiders with the largest holdings of Kymera Therapeutics?: Kymera Therapeutics' top insider shareholders include:
Bros Advisors Lp Baker (Director)
Venture Fund X LP Atlas (Major Shareholder)
Bvf Partners L P/Il (Director)
Bruce Booth (Director)
Nello Mainolfi (CEO)
Bruce N Jacobs (CFO)
Jared Gollob (Insider)
Ellen Chiniara (Insider)
Jeremy G Chadwick (COO)
Richard Chesworth (Insider)
Learn More about top insider investors at Kymera Therapeutics.
Who are the major institutional investors of Kymera Therapeutics?: Kymera Therapeutics' top institutional shareholders include:
BlackRock Inc. — 6.73%
Wellington Management Group LLP — 4.42%
Atlas Venture Life Science Advisors LLC — 3.42%
Merck & Co. Inc. — 0.94%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.89%
Bank of America Corp DE — 0.45%
Learn More about top institutional investors of Kymera Therapeutics stock.
Which major investors are selling Kymera Therapeutics stock?: During the previous quarter, KYMR stock was sold by these institutional investors:
Atlas Venture Life Science Advisors LLC
Wellington Management Group LLP
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Alyeska Investment Group L.P.
Yiheng Capital Management L.P.
California State Teachers Retirement System
Algert Global LLC
Arizona State Retirement System
Within the previous year, company insiders that have sold Kymera Therapeutics company stock include:
Bruce Booth (Director)
Nello Mainolfi (CEO)
Bruce N Jacobs (CFO)
Bvf Partners L P/Il (Director)
Jared Gollob (Insider)
Jeremy G Chadwick (COO)
Noah Goodman (Insider)
Brian Adams (Insider)
Elena Ridloff (Director)
Jeffrey W Albers (Director)
Learn More investors selling Kymera Therapeutics stock.
Which major investors are buying Kymera Therapeutics stock?: In the previous quarter, KYMR stock was purchased by institutional investors including:
BlackRock Inc.
Merck & Co. Inc.
Bank of America Corp DE
Bank of New York Mellon Corp
Eagle Health Investments LP
TimesSquare Capital Management LLC
Connor Clark & Lunn Investment Management Ltd.
The Manufacturers Life Insurance Company
Within the previous year, these company insiders have bought Kymera Therapeutics stock:
Bros Advisors Lp Baker (Director)
Bvf Partners L P/Il (Director)
Learn More investors buying Kymera Therapeutics stock.